Olin Corporation (NYSE: OLN) — FY 2023 Form 10-K
Reporting period: Fiscal year ended December 31, 2023. Comparisons are primarily with FY 2022; this filing is an annual report, not a standalone fourth-quarter earnings report.
Business context
Olin is a vertically integrated chemical manufacturer and U.S. ammunition producer. FY 2023 sales mix was Chlor Alkali Products and Vinyls 58%, Epoxy 20%, and Winchester 22%. Approximately 33% of sales were generated outside the United States. No customer represented more than 10% of sales.
Financial performance and position
| Metric | FY 2023 | FY 2022 |
|---|---|---|
| Sales | $6.833 billion | $9.376 billion |
| Gross margin | $1.166 billion; 17% of sales | $2.182 billion; 23% of sales |
| Operating income | $712.1 million | $1.779 billion |
| Net income attributable to Olin | $460.2 million | $1.327 billion |
| Diluted earnings per share | $3.57 | $8.94 |
| Cash provided by operating activities | $974.3 million | $1.922 billion |
| Capital expenditures | $236.0 million | $236.9 million |
| Cash and cash equivalents, year-end | $170.3 million | $194.0 million |
| Total debt, year-end | $2.670 billion | $2.581 billion |
| Current ratio | 1.3 | 1.4 |
Sales fell 27% and net income attributable to Olin fell 65% year over year, mainly reflecting lower operating results across all three segments. Lower income and working-capital movements drove the $947.6 million reduction in operating cash flow. Total debt was 54.1% of total capitalization, versus 50.4% a year earlier; $78.8 million of debt was due within one year. Olin had $1.132 billion available under its $1.2 billion revolving credit facility, subject to facility terms and covenants, and reported compliance with debt covenants at year-end.
Olin repurchased and retired 13.3 million shares for $711.3 million during 2023; $997.0 million remained authorized under its $2.0 billion repurchase program at year-end. The annual dividend was $0.80 per share.
Segment results and material changes
- Chlor Alkali Products and Vinyls: Sales were $3.995 billion, down 21%; segment income was $664.2 million, down from $1.181 billion. Lower volumes and prices were partly offset by lower energy, raw-material, and operating costs. A Freeport VCM-plant turnaround and related operating issues reduced profit through higher costs and lost sales by $104.2 million; normal operations resumed in the latter half of Q3.
- Epoxy: Sales were $1.329 billion, down 51%; segment loss was $31.0 million versus income of $388.5 million. Results reflected facility closures, lower prices and volumes, and increased Asian exports into European and North American markets, partly offset by lower input and operating costs.
- Winchester: Sales were $1.509 billion, down 6%; segment income was $255.6 million, down from $372.9 million. Lower commercial volumes and pricing were partly offset by higher domestic and international military sales.
Outlook, management commentary, and risks
- Management expected Q1 2024 operating results to be slightly above Q4 2023: Chemicals slightly higher and Winchester higher sequentially. It expected the initiative to reduce participation in ECU markets and adjust operating rates to continue through most of Q1.
- For 2024, management projected capital spending of $225–$250 million, depreciation and amortization of $500–$525 million, an effective tax rate of 25%–30%, and a cash tax rate of 35%–40%. Other corporate and unallocated costs were expected to exceed 2023’s $106.3 million.
- Olin recorded $89.6 million of restructuring charges in 2023, including $73.4 million for the Epoxy footprint optimization. It expected about $25 million of additional charges through 2025 for that plan, as well as about $45 million through 2027 for other previously disclosed plans.
- Environmental liabilities were $153.6 million at year-end. Olin estimated up to $80 million of reasonably possible additional contingent environmental liabilities beyond recorded reserves. It forecast 2024 environmental-related cash outlays of about $210 million overall, including $25–$35 million for investigation and remediation.
- Pending U.S. and Canadian caustic-soda antitrust class actions remain unresolved; Olin said potential losses are not currently estimable and an unfavorable outcome could materially affect results, cash flows, or financial position. Other risks include cyclical demand and pricing, energy and feedstock costs, production or transport disruptions, regulation, and debt covenant constraints.
- Olin announced that Kenneth Lane would become CEO effective March 18, 2024, succeeding Scott Sutton. This leadership change was announced after the reporting period.
Key facts for investors to verify
- Whether chemical demand, pricing, and Asian epoxy exports improve, and whether the operating-rate actions support margins.
- How quickly Winchester commercial demand recovers relative to military-contract sales and its reported backlog of approximately $914 million as of January 31, 2024.
- Execution costs and expected benefits of Epoxy restructuring, including further facility or capacity changes.
- Environmental reserve adequacy and the outcome of caustic-soda litigation and other contingencies.
- Debt maturities, borrowing-base availability, covenant headroom, and the effect of continued share repurchases on leverage and liquidity.
- Performance through the CEO transition and delivery against the company’s 2024 outlook.